Analysts Set Cardinal Health, Inc. (NYSE:CAH) PT at $133.29

Cardinal Health, Inc. (NYSE:CAH) has earned a consensus rating of “Moderate Buy” from the fifteen analysts that are currently covering the firm, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $134.64.

Several equities analysts have recently commented on the stock. UBS Group boosted their price target on shares of Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a report on Monday, November 4th. Morgan Stanley boosted their target price on Cardinal Health from $127.00 to $136.00 and gave the company an “overweight” rating in a research note on Tuesday, December 17th. Wells Fargo & Company raised Cardinal Health from an “underweight” rating to an “equal weight” rating and raised their price target for the stock from $101.00 to $127.00 in a research note on Friday, December 13th. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Finally, TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th.

Cardinal Health Stock Down 0.3 %

Shares of NYSE CAH opened at $128.89 on Wednesday. The stock has a market cap of $31.19 billion, a P/E ratio of 25.08, a P/E/G ratio of 1.57 and a beta of 0.63. The firm’s 50-day simple moving average is $121.36 and its 200 day simple moving average is $113.16. Cardinal Health has a fifty-two week low of $93.17 and a fifty-two week high of $129.68.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $52.28 billion for the quarter, compared to analysts’ expectations of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. The business’s revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.73 EPS. On average, sell-side analysts anticipate that Cardinal Health will post 7.82 earnings per share for the current fiscal year.

Cardinal Health Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were given a dividend of $0.5056 per share. The ex-dividend date of this dividend was Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.57%. Cardinal Health’s payout ratio is 39.30%.

Hedge Funds Weigh In On Cardinal Health

Several hedge funds and other institutional investors have recently made changes to their positions in CAH. Eastern Bank acquired a new stake in shares of Cardinal Health in the 3rd quarter valued at approximately $25,000. Frazier Financial Advisors LLC increased its holdings in shares of Cardinal Health by 69.8% during the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after buying an additional 104 shares in the last quarter. Hara Capital LLC acquired a new position in shares of Cardinal Health during the third quarter worth $31,000. AM Squared Ltd bought a new position in shares of Cardinal Health in the 3rd quarter valued at $33,000. Finally, HHM Wealth Advisors LLC boosted its holdings in shares of Cardinal Health by 57.6% during the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock valued at $47,000 after acquiring an additional 144 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.